A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking oral semaglutide (Rybelsus) who want to monitor how their body is responding over time.
21 biomarkers as listed by Blue Horizon Medicals.
This panel groups together markers commonly used to keep an eye on how the body is coping with ongoing GLP-1 therapy taken by mouth. The kidney markers (sodium, urea, chloride, eGFR and creatinine) are commonly used to assess hydration and kidney function; the liver markers (total protein, albumin, globulin, ALP, ALT, AST, GGT and bilirubin) are commonly used to assess how the liver is processing the medication; the lipid profile (total cholesterol, non-HDL, triglycerides, HDL and LDL) is commonly used to assess cardiovascular risk factors; HbA1c is used to assess longer-term blood sugar control; and lipase is commonly used to assess pancreatic health. The provider suggests a baseline test before your first dose, then a recheck every 3 months or whenever your dose changes.
There is no comparison group set up for this exact test, so it cannot be measured against named rivals, but against the wider set of metabolism tests we track its £129.75 price sits close to the £124.38 median, only a little above it. At 21 markers it is one of the more thorough panels in that wider group. Collection is a venous blood draw at a clinic or with a nurse home visit, and results come back within 5 days.
Clinical depth and clarity both score strongly here, reflecting the size of the panel and the detail in the listing, which sets out the description, full biomarker list, sample type, turnaround and collection options, though not what the report itself looks like. Value for money is more middling, since the price sits slightly above the wider metabolism-test median rather than clearly below it. Results are reviewed by a doctor, which supports the results and follow-up score, while collection convenience is held back by the need for a venous draw rather than an at-home kit.
This suits you if you are taking, or about to start, oral semaglutide and want a broad set of markers to track alongside your treatment, ideally as a baseline before your first dose and then every 3 months or after a dose change. It is a wide panel rather than a narrow one, so it may cover more than you need if you only want to track one or two specific markers. There is no comparison group in our data for this exact test, so we cannot point you to a cheaper or deeper named alternative.
You give a venous blood sample, either at a clinic appointment or with a nurse home visit. The sample is sent to the lab and tested across kidney, liver, lipid, HbA1c and lipase markers, and a doctor reviews the results before they are returned to you. Results are provided within 5 days of your sample being received.
This 21-marker panel covers kidney, liver, lipid, HbA1c and lipase markers for £129.75, close to the £124.38 median for similarly sized metabolism tests we track. It is pitched specifically at people taking oral semaglutide (Rybelsus), with a baseline test suggested before starting and a recheck every 3 months or after a dose change. There is no comparison group of directly equivalent tests, so we cannot say how it compares with named rivals.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
21 biomarkers, placing it in the 78th percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£129.75 against a median of £124.38 for the 14 similarly sized metabolism tests we track (+4%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
Wide 21-marker panel for ongoing Wegovy monitoring
This is a 21-marker blood panel covering kidney, liver, lipid and blood sugar markers, intended for people taking Wegovy (semaglutide) for weight management who want to monitor these systems over time. It suits ongoing monitoring rather than one-off screening.
21-marker monitoring panel for Saxenda users
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking daily injectable liraglutide (Saxenda) who want to monitor how their body is responding over time.
